Skip to main content
. 2023 Jul 21;15(14):3708. doi: 10.3390/cancers15143708

Figure 2.

Figure 2

(a) HeatMap demonstrating the metabolites differences between cutaneous melanoma versus mucosal and uveal. (b) Random Forest analysis, cutaneous versus mucosal and uveal melanomas presented with distinct levels of 3-hydroxykynurenine and kynurenic acid. (c) Scheme of Kynurenine Pathway. (d) Conversion rate (mean, SD) estimated by kynurenine/tryptophan ratio (Kyn/Tryp), levels of tryptophan, and levels of kynurenine according to melanoma subtypes. (e) Levels of 3-hydroxykynurenine and kynurenic acid by melanoma subtypes, and kynurenic acid/3-hydroxykynurenine (KA/3-HKyn) ratio. ns = not statistically significant; ** p < 0.01; **** p < 0.0001.